Clinical Trial Update: Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study [Phase 2]

View source ↗

Summary

Phase 2 double-blind, placebo-controlled trial evaluating taurine as an anti-manic agent in bipolar disorder with mania.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression
• Bipolar Disorder
• Mania

Drugs mentioned

• Taurine (taurine)

Snippet

Sponsor: Mclean Hospital | Conditions: Bipolar Disorder, Mania | Phase 2 | Status: COMPLETED